Skip to main content
. 2017 Mar 17;8(23):37308–37320. doi: 10.18632/oncotarget.16307

Table 5. PPARG-PPARGC1A-PPARGC1B haplotype frequencies (%) in cases and controls and risk of type 2 diabetes.

Haplotypes Cases (n=1004) Controls (n=1564) Crude OR (95% CI) P
n (%) n (%)
C C T C G G G 329(33.13) 507(32.50) 1.00
C C C T G G G 133(13.39) 244(15.64) 0.84(0.65-1.08) 0.176
C C C C G G G 129(13.00) 200(12.82) 0.99(0.77-1.29) 0.964
C C C C A G G 98(9.82) 188(12.05) 0.80(0.61-1.06) 0.126
C T T C G G G 91(9.16) 101(6.47) 1.39(1.01-1.90) 0.041
C T C T G G G 57(5.74) 48(3.08) 1.83(1.22-2.75) 0.003
C T C C G G G 32(3.22) 72(4.62) 0.68(0.44-1.06) 0.090
C C T C G C A 31(3.12) 32(2.05) 1.49(0.89-2.49) 0.124
C T C C A G G 24(2.42) 40(2.56) 0.92(0.55-1.56) 0.770
G T T C G G G 15(1.51) 27(1.73) 0.86(0.45-1.63) 0.637
C C C C G C A 13(1.31) 16(1.03) 1.25(0.59-2.64) 0.553
G T C T G G G 11(1.11) 15(0.96) 1.13(0.51-2.49) 0.762
C C C C A C A 0 (0) 10(0.64) - 0.008
Others 30(3.02) 60(3.85) 0.77(.49-1.22) 0.265

With the order of PPARG rs1801282 C>G, PPARG rs3856806 C>T, PPARGC1A rs8192678 C>T, PPARGC1A rs2970847 C>T, PPARGC1A rs3736265 G>A, PPARGC1B rs7732671 G>C and PPARGC1B rs17572019 G>A polymorphisms in gene position. Bold values are statistically significant (P < 0.05).